华恒生物
(688639)
| 流通市值：64.03亿 | | | 总市值：64.03亿 |
| 流通股本：2.50亿 | | | 总股本：2.50亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 446,179,600.53 | 284,122,206.43 | 492,952,452.97 | 379,270,706.58 |
| 应收票据及应收账款 | 377,847,673.82 | 391,530,619.12 | 396,453,589.45 | 360,719,884.84 |
| 其中：应收票据 | 113,255,596.93 | 120,285,252.28 | 128,569,439.34 | 52,994,189.64 |
| 应收账款 | 264,592,076.89 | 271,245,366.84 | 267,884,150.11 | 307,725,695.2 |
| 应收款项融资 | 19,203,659.8 | 25,244,452.19 | 19,443,895.55 | 14,723,256.64 |
| 预付款项 | 79,169,893.36 | 47,962,533.79 | 81,156,503.44 | 39,211,011.93 |
| 其他应收款合计 | 14,723,438.97 | 17,446,725.25 | 12,400,075.3 | 7,654,399.77 |
| 存货 | 627,744,841.44 | 532,126,830.56 | 503,592,135.11 | 508,956,661.97 |
| 其他流动资产 | 167,345,192.69 | 165,649,730.89 | 148,264,447.83 | 142,266,032.44 |
| 流动资产合计 | 1,732,214,300.61 | 1,464,083,098.23 | 1,654,263,099.65 | 1,452,801,954.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,987,977.37 | 5,054,377.87 | 5,225,092.91 | 5,311,167.2 |
| 其他非流动金融资产 | 119,400,033.33 | 119,400,033.33 | 116,600,033.33 | 116,600,033.33 |
| 固定资产 | 2,623,502,389.14 | 2,651,264,903.41 | 2,279,888,780.57 | 2,026,666,005.14 |
| 在建工程 | 1,204,141,840.49 | 1,192,386,961.67 | 1,253,293,352.17 | 1,378,933,239.9 |
| 无形资产 | 148,578,515.81 | 150,044,791.62 | 150,955,976.36 | 151,818,515.11 |
| 长期待摊费用 | 15,112,093.65 | 13,642,958.02 | 13,386,353.22 | 9,805,459.15 |
| 递延所得税资产 | 128,086,080.09 | 145,296,844.94 | 126,897,597.59 | 107,258,819.51 |
| 其他非流动资产 | 49,891,101.93 | 33,507,510.36 | 71,154,995.62 | 52,426,666.06 |
| 非流动资产合计 | 4,293,700,031.81 | 4,310,598,381.22 | 4,017,402,181.77 | 3,848,819,905.4 |
| 资产总计 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 | 5,301,621,859.57 |
| 流动负债: | | | | |
| 短期借款 | 221,093,043.89 | 123,381,386.79 | 135,575,029.15 | 249,231,644.67 |
| 衍生金融负债 | 205,733.92 | - | 104,550 | - |
| 应付票据及应付账款 | 616,712,737.73 | 712,680,474.72 | 538,280,119.08 | 586,681,988.42 |
| 应付账款 | 616,712,737.73 | 712,680,474.72 | 538,280,119.08 | 586,681,988.42 |
| 合同负债 | 32,243,359.93 | 16,998,506.07 | 37,335,749.17 | 18,563,044.56 |
| 应付职工薪酬 | 29,457,539.44 | 49,112,998.47 | 38,888,138.39 | 36,186,385.06 |
| 应交税费 | 11,914,782.4 | 7,566,940.1 | 14,191,541.66 | 14,175,162.5 |
| 其他应付款合计 | 22,969,686.85 | 23,672,427.86 | 25,918,208.29 | 84,440,133.16 |
| 应付股利 | - | - | - | 62,404,773.25 |
| 一年内到期的非流动负债 | 421,164,072.26 | 363,031,639.1 | 308,190,795.3 | 302,201,235.23 |
| 其他流动负债 | 72,018,960.8 | 42,877,768.86 | 46,684,161.28 | 36,832,999.43 |
| 流动负债合计 | 1,427,779,917.22 | 1,339,322,141.97 | 1,145,168,292.32 | 1,328,312,593.03 |
| 非流动负债: | | | | |
| 长期借款 | 1,725,051,609.56 | 1,572,426,984.86 | 1,648,390,496.9 | 1,160,802,597.62 |
| 递延收益 | 91,814,267.29 | 94,749,607.75 | 84,909,292.56 | 87,178,997.62 |
| 递延所得税负债 | 112,415,879.35 | 136,322,958.25 | 125,495,523.78 | 107,727,100.6 |
| 非流动负债合计 | 1,929,281,756.2 | 1,803,499,550.86 | 1,858,795,313.24 | 1,355,708,695.84 |
| 负债合计 | 3,357,061,673.42 | 3,142,821,692.83 | 3,003,963,605.56 | 2,684,021,288.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 250,115,693 | 250,115,693 | 250,115,693 | 250,115,693 |
| 资本公积 | 1,217,719,545.95 | 1,217,719,545.95 | 1,217,719,545.95 | 1,217,719,545.95 |
| 减:库存股 | 50,012,725.12 | 50,012,725.12 | 50,012,725.12 | 50,012,725.12 |
| 其他综合收益 | -104,911.08 | 428,012.31 | 706,404.91 | 881,266.9 |
| 盈余公积 | 90,706,766.16 | 90,706,766.16 | 78,416,832.26 | 78,416,832.26 |
| 未分配利润 | 1,179,822,148.36 | 1,137,724,813.05 | 1,185,224,145.03 | 1,132,494,754.52 |
| 归属于母公司股东权益合计 | 2,688,246,517.27 | 2,646,682,105.35 | 2,682,169,896.03 | 2,629,615,367.51 |
| 少数股东权益 | -19,393,858.27 | -14,822,318.73 | -14,468,220.17 | -12,014,796.81 |
| 股东权益合计 | 2,668,852,659 | 2,631,859,786.62 | 2,667,701,675.86 | 2,617,600,570.7 |
| 负债和股东权益合计 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 | 5,301,621,859.57 |
| 公告日期 | 2026-04-23 | 2026-03-18 | 2025-10-28 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |